Bangshil
and Fortege
in
Benign
Prostatic Hypertrophy
BY M.A. Wahab, BSc, MBBS,Past Graduate Student,
B.M.Tejwani, MD., Lecturer
in Medicine,
L.P.Pathak,
MB, Lecturer in Medicine.
and
Department of
Medicine,
Current
Medical Practice, Vol. 15.No.12,P.1078. Dec. 1971.
Common
genito-urinary complaints like prostatitis,
benign enlargement of prostate with urinary complaints, urethritis,
balanitis etc.are often associated with various micturition
troubles, which are severe, persistent and often distressing even after
prolonged and exhaustive treatment with the available standard drugs. A few
elderly males usually complain of frequency, hesitancy, urgency and
precipitancy of micturition. In such circumstances a
rectal and urological examination reveals the presence of an enlarged Prostate.
Prostatic Hypertrophy can be benign or malignant with one or more of the above
complaints with superadded urinary infection.
Material and
Methods:
Twelve
proved cases of prostatic hypertrophy from 50-75 years of age were taken for
this trial from the indoor patients of
Dose:
Two
tablets of Fortege (Alarsin) and two tablets Bangshil
(Alarsin) were given twice daily for the first 4
weeks. In cases who responded, the drug was continued for another 8 weeks.
An
overall clinical evaluation was done on the basis of subjective improvement of
symptoms and urinary findings.
Observations and Conclusions:
TABLE-1
RESULTS
No.of
cases. Marked improvement. Doubtful improvement
12 9 3
TABLE-2
Duration of
treatment and relief.
Treatment Observations
3-6
days. Relief
in burning and frequency of Micturition.
2 weeks Relief
in hesitancy, urgency and precipitancy.
3
weeks. Marked
relief and improvement in general well-being.
The
added symptoms of associated urinary tract infection such as burning and
frequency of micturition showed a marked relief in
3-6 days of treatment. Symptoms of Prostatic hypertrophy i.e. hesistancy, urgency, frequency and precipitancy showed
progressive improvement from the second week onwards. In the third week of
trial one patient could pass urine comfortably per urethra. Eight cases showed
satisfactory improvement from the third week onwards, three cases showed
doubtful response to treatment. General health improvement was observed in all
the cases and no toxic reactions were reported during three months of
treatment.
It
is rather difficult to draw a definite conclusion out of this limited study.
The results, however, indicate that the combination of these two drugs is quite
effective in improving the symptomatology of most of
the cases with benign prostatic enlargement. However, further work on the same
lines with pathological and bacteriological aids would be desirable.
Acknowledgement:
We
are thankful to the Superintendent of Medical College,